Twitter | Search | |
Search Refresh
Mary Cushman MD 9 Dec 17
: to prevent in chemo patients: YES if high Khorana Score. 4.3% absolute risk reduction. Withhold if incr bleeding risk. Overall results below. .
Reply Retweet Like
Dr. Maria T DeSancho 12 Jul 17
Our second poster presentation#ISTH2017women with placenta malperfusion &
Reply Retweet Like
Anticoag Team HEFT 1 May 18
Dr. Smith discussing treatment in patients with renal impairment.
Reply Retweet Like
Nawaf Alenzi⚕️, 21 Feb 18
low molecular weigh heparin Unfractionated heparin
Reply Retweet Like
manuel monreal 14 Feb 18
In a propensity-matched analysis, patients receiving <150 IU/kg/day had more DVT recurrences but fewer fatal Any plausible explanation? How should we treat our cancer patients with VTE? LMWH, ok. But, what doses?
Reply Retweet Like
Michael Makris May 19
Considering how long we have been using low molecular weight heparin () in adults, it is remarkable that the FDA has only just approved the first LMWH for use in children.
Reply Retweet Like
The Phlegmfighter Mar 30
1/x. Hey guys and gals, The Phlegmfighter here. I decided to put together a tweetorial on how to treat : 1.) If not in shock give a derivative preferably . 2.) If in shock, from PE, for reals, 2 readings <90, give . And oh yeah, x=1.
Reply Retweet Like
Anesthesia&CritCare 12 Sep 15
The end of peri-operative bridging with in patients with atrial fibrillation on warfarin?
Reply Retweet Like
Saskia Middeldorp 17 Aug 17
. or not? I just randomized a pregnant 🚺 to no treatment. Grateful for participation
Reply Retweet Like
Raul Cordoba, MD, PhD 15 Jun 17
Replying to @DrRaulCordoba
Of interest, high rate of in treated with DA-EPOCH-R. Need of prophylactic ?
Reply Retweet Like
Mandy Lauw Dec 3
Dr. Bates highlights in . VTE recommended with 1-2 daily without monitoring of anti-Xa levels
Reply Retweet Like
USMLE Case Review 2 Feb 16
Replying to @medrx_education
AntiPhosphoLipid Syndrome - Prophylaxis in : Low Dose + to avoid recurrent abortions.
Reply Retweet Like
Martina Murphy, MD Aug 21
Today enrolled the first US patient in the Caravaggio trial examining vs for primary treatment of cancer ! Look forward to more data to help guide decision making for our patients with .
Reply Retweet Like
Geoff Barnes 24 Jun 15
Network meta-analysis: & are equally effective & safe for cancer tx, but small #'s & indirect comparison
Reply Retweet Like
BloodWork 23 May 18
in - and equivalent efficacy but bit more bleeding with the . reports
Reply Retweet Like
Thrombosis Adviser 10 Jul 17
Development of low molecular weight heparin () & more recently has revolutionised mgmnt of pts w
Reply Retweet Like
Saskia Middeldorp 11 Aug 17
Great: 450 pts included in . with 2 doses to prevent Recurrent in
Reply Retweet Like
Tania Ahuja Apr 29
we report a case of an dilemma after device placement in ❣️ 💊💉💊 😳
Reply Retweet Like
BloodWork 7 Mar 17
Does twice daily dosing improve therapeutic and toxicity pharmacokinetics?
Reply Retweet Like
Stephane Jaglin 13 Apr 17
Advised Anaesthetic colleague on correct dose of for extreme weight Patient 140kg (40mg bd)
Reply Retweet Like